Search results for: 'signaling pathways cancer biology cell proliferation viability cytotoxicity'
- C3430 CFDA-SESummary: A stable, cell-permeable dye commonly used in cell proliferation assay
- BA9734 MC-1-F2Summary: MC-1-F2 is an inhibitor that reduces epithelial-mesenchymal transition (EMT) labeling, inhibits cancer stem cell (CSC) properties, and decreases invasiveness of denuded resistant prostate cancer (CRPC) cell lines in breast cancer cell lines.
- BA8301 NPD10084Summary: NPD10084 is a pyruvate kinase inhibitor that inhibits non-glycolytic signaling in cancer cells.
- P1025 IL-7, murine recombinantSummary: IL-7, lymphoid cell growth factor, expressed in E.Coli, cross-species reactive.
- BA9119 TDI-011536Summary: TDI-011536 is a potent kinase inhibitor that interrupts signaling and may initiate proliferation of damaged cardiomyocytes.
- B2282 KX2-3911 CitationSummary: Src inhibitor,highly selective
- BA7801 TAT-cyclo-CLLFVYSummary: TAT-cyclo-CLLFVY is a heterodimerized cyclic peptide inhibitor that inhibits hypoxic signaling in cancer cells.
- BA2872 PTC-028Summary: PTC-028 is an orally effective inhibitor of stem cell factor for the study of ovarian cancer.
- BA6351 OritinibSummary: SH-1028 is an irreversible third-generation that overcomes T790M-mediated resistance in non-small cell lung cancer.
- BA6139 Q134RSummary: Q134R, a neuroprotective hydroxyquinoline derivative, inhibits nuclear factors that activate T cell signaling.